Itraconazol Tecnigen (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, preventing the synthesis of ergosterol, an essential component of fungal cell membranes. This disruption impairs membrane integrity and inhibits fungal growth, providing a broad spectrum of antifungal activity.

The dose of Itraconazol Tecnigen is individualized by the prescriber based on the specific infection, its severity, patient weight, age, renal and hepatic function, and any concomitant medications. No fixed regimen is provided here; the prescribing clinician sets the appropriate dosage.

Safety data for itraconazole in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the treating physician in consultation with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with other azole antifungals, itraconazole offers a broader spectrum against molds such as Aspergillus and has a longer half‑life, allowing once‑daily dosing in many regimens. However, it has a higher potential for drug‑drug interactions due to strong CYP3A4 inhibition, which may limit its use in patients on multiple concurrent medications.

Store Itraconazol Tecnigen below 25 °C in its original packaging, protecting it from moisture, heat, and direct light. Do not store in bathrooms or near kitchen appliances, and keep the container tightly closed when not in use.

Itraconazol Tecnigen is taken orally, usually with food or a full glass of water to enhance absorption. The exact administration instructions, including timing relative to meals, are provided by the prescribing clinician and should be followed precisely.

The most serious risks include hepatotoxicity leading to severe liver injury, life‑threatening cardiac events such as congestive heart failure or arrhythmias, and severe skin reactions like Stevens‑Johnson syndrome. Patients should be monitored closely for signs of liver dysfunction, cardiac symptoms, or rash.

Itraconazole is contraindicated in patients with known hypersensitivity to itraconazole or any azole antifungal, those with uncontrolled heart failure, and individuals taking contraindicated medications that strongly induce CYP3A4. Pregnant or breastfeeding women should use it only if clearly needed and after medical consultation.